Background Venovenous extracorporeal membrane oxygenation (ECMO) can be
considered for patients with COVID-19-associated acute respiratory distress syndrome …

Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

Background Multiple major health organisations recommend the use of extracorporeal
membrane oxygenation (ECMO) support for COVID-19-related acute hypoxaemic …

Survival of coronavirus disease 2019 (COVID-19) patients with severe respiratory failure
treated with venovenous extracorporeal membrane oxygenation (VV ECMO) ranges around …

Background Extracorporeal membrane oxygenation (ECMO) has been widely used in
patients with COVID-19, but uncertainty remains about the determinants of in-hospital …

Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19
has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased …

Objective To estimate the effect of extracorporeal membrane oxygenation (ECMO)
compared with conventional mechanical ventilation on outcomes of patients with covid-19 …

Background Extracorporeal membrane oxygenation (ECMO) has been used extensively for
coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) …

Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …

BACKGROUND In the context of the coronavirus disease 2019 (COVID-19) pandemic, many
retrospective single-centre or specialised centre reports have shown promising mortality …